Clinical Trials Directory

Trials / Unknown

UnknownNCT06124391

Novel Subtypes of Polycystic Ovary Syndrome

An Evidence-Based Novel Subtypes of Polycystic Ovary Syndrome and Their Association With Outcomes: a Large Cohort Study

Status
Unknown
Phase
Study type
Observational
Enrollment
50,000 (estimated)
Sponsor
Shandong University · Academic / Other
Sex
Female
Age
18 Years – 45 Years
Healthy volunteers
Accepted

Summary

To classify subtypes of Polycystic Ovary Syndrome (PCOS) using machine-learning algorithms, and compare the reproductive and metabolic characteristics and IVF outcomes across these identified subtypes.

Detailed description

In this study, we've developed a machine-learning model to classify PCOS patients into four subtypes based on nine clinical characteristics. The goal of this observational study is to: * Learn about different PCOS subtypes using our classification model. * Compare the reproductive and metabolic features of these subtypes. * Assess the outcomes of IVF among different PCOS subtypes. * Prospective 6.5-year follow-up data will be collected. Participants will: * Undergo a telephone interview to gather details on: 1. Current physical stats like height and weight. 2. Reproductive history, including pregnancies and childbirths in recent years. 3. Details about any IVF treatments. 4. Current status of conditions such as PCOS, Type 2 Diabetes, hypertension, and dyslipidemia. * Be invited for a physical examination that includes: 1. Measurements such as height, weight, blood pressure, and body circumferences. 2. Laboratory tests for endocrine and metabolic conditions. 3. Ultrasound scans of the ovaries and liver.

Conditions

Interventions

TypeNameDescription
OTHERLong-term follow-upParticipants diagnosed with PCOS were not subjected to any specific intervention post-diagnosis. Instead, they were followed up after 6.5 years to assess various outcomes related to PCOS and associated conditions.

Timeline

Start date
2021-01-01
Primary completion
2025-12-30
Completion
2025-12-30
First posted
2023-11-09
Last updated
2023-11-30

Locations

11 sites across 6 countries: United States, Brazil, China, Singapore, Sweden, Turkey (Türkiye)

Source: ClinicalTrials.gov record NCT06124391. Inclusion in this directory is not an endorsement.